$RDGT

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results

Ridgetech, Inc. (Nasdaq: RDGT) reported fiscal year 2026 results for the year ended March 31, 2026. Revenue rose 10.2% to $132.16 million, driven by a full year of Allright’s online platform after its Feb. 28, 2025 acquisition. Gross profit increased 23.8% to $4.75 million, but net loss was $1.25 million versus net income $10.20 million a year earlier.

Original reporting
Published Jul 31, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 1:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RDGT
Neutral
medium confidence
Mentioned
$RDGT
Relevance
7/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$RDGTNeutralMed
01

Why it matters

Traders will likely focus on whether the Allright-driven online mix can lift gross margin above the current 3.6% level and whether the offline credit-sales risk mitigation stabilizes cash flows.

02

Market read

FY2026 results show revenue growth and improved gross profit, but continued net loss and very low gross margin, with offline revenue pressured by credit-sales discontinuation.

03

What to watch

Offline wholesale revenue fell due to discontinued credit sales after delayed repayments, which could reduce future bad-debt risk but also suppress top-line growth.

Relevance 7/10Novelty 7/10Timing: pre-market today (FY2026 results released July 31, 2026)

Background

Ridgetech is a China healthcare product distributor that completed a strategic transition to a wholesale-focused model via acquisition of Allright and divestiture of its retail drugstore business.

Company-level read

Ticker impact

$RDGTNeutralMedium confidence
Context

Ridgetech reported FY2026 results, including revenue up 10.2% to $132.16M and shifting to a wholesale-focused model after acquiring Allright.

Expected impact

Near-term volatility likely as traders weigh revenue growth versus continued low gross margin (3.6%) and net loss of $1.25M.

Evidence & confidence

The release provides concrete financial datapoints (revenue, gross margin, net loss) and explains the offline credit-sales risk mitigation that reduced offline revenue.

Market effects

Highlights execution risk in China pharmaceutical distribution economics, with gross margin staying low even after mix shift to online.

China healthcare distribution demand and e-commerce channel adoption remain key drivers for small-cap distributors.

Limited, as the company is China-focused and the disclosure is primarily company-specific.

Counterpoint

The large online revenue jump is largely accounting timing from a full year of Allright, so the underlying profitability trend may be improving but not yet reflected in gross margin.

Key entities

  • Ridgetech, Inc.

    Nasdaq-listed wholesale distributor of pharmaceutical and healthcare products in China; reported FY2026 financial results and business-model transition.

  • Allright (Hangzhou) Internet Technology Co. Ltd

    Online and offline wholesale distributor acquired in Feb 2025; its full-year contribution drove FY2026 online revenue growth.

Related articles

$RDGTMed

Ridgetech Inc. (RDGT): Financial results for FY2026

Ridgetech Inc. (RDGT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) (“Ridgetech” or the “Company”), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced

$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.

$AMZNMedAI 8/10

Should You Buy Amazon Stock For The Demand AWS Cannot Yet Serve?

Amazon.com (AMZN) stock is down 13% from its 52-week high, despite AWS's 36.7% YOY revenue growth in Q2 2026. AWS's backlog of committed contracts reached $496 billion, with demand outpacing capacity. AWS's operating margin improved 520 basis points YOY, excluding energy contract gains. Management attributes growth to AI workloads and efficient capacity use.

$ASMLMedAI 8/10

Weakness Is an Opportunity for Long-Term ASML Stock Investors

ASML's High-NA technology is gaining traction among chipmakers like Samsung, Intel, and TSMC, crucial for its long-term outlook. Q2 earnings beat estimates with €7.59 EPS and €9.33B revenue. ASML raised full-year 2026 sales guidance to €43B-€45B. Analysts have a consensus 'Hold' rating, with a mean price target of $2,350.75, implying 56% upside.

$LENMedAI 8/10

Lennar (LEN) Q3 2026 Earnings Call Transcript

Lennar (LEN) reported Q3 2026 net earnings of $284M, down 52% YoY, with GAAP EPS at $1.19. Revenues were $8B, driven by home sales. New orders and deliveries decreased due to affordability constraints. The company revised full-year delivery guidance to 80K-81K homes. Management cited higher interest rates and labor pressures as key challenges.

$PANWMedAI 8/10

Jim Cramer Prefers Palo Alto (PANW) Over SentinelOne (S)

Jim Cramer expressed preference for Palo Alto Networks (PANW) over SentinelOne (S) during a lightning round, citing his Charitable Trust's ownership of PANW and CrowdStrike (CRWD). PANW reported fiscal Q4 2026 revenue of $3.41 billion, up 34% YoY, while S reported fiscal Q2 2027 revenue of $292 million, up 21% YoY. PANW's CEO highlighted AI's impact on cybersecurity priorities. Both companies face challenges, including S's GAAP profitability and PANW's margin pressure. Hedge funds hold more PANW